Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 19.70
+0.20 (1.03%)
Last updated: Apr 29, 2026, 12:00 PM CET
Vytrus Biotech Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 3.38 | 2.53 | 1.1 | 0.72 | 1.28 | Upgrade
|
| Short-Term Investments | 0.06 | 0 | 0 | - | 0 | Upgrade
|
| Cash & Short-Term Investments | 3.44 | 2.53 | 1.11 | 0.72 | 1.28 | Upgrade
|
| Cash Growth | 36.01% | 128.81% | 52.54% | -43.56% | 17.37% | Upgrade
|
| Accounts Receivable | 0.98 | 0.62 | 0.55 | 0.44 | 0.21 | Upgrade
|
| Other Receivables | 0.33 | 0.11 | 0.23 | 0.09 | 0.05 | Upgrade
|
| Receivables | 1.31 | 0.73 | 0.78 | 0.53 | 0.27 | Upgrade
|
| Inventory | 0.64 | 0.54 | 0.56 | 0.43 | 0.26 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.01 | Upgrade
|
| Total Current Assets | 5.39 | 3.79 | 2.45 | 1.68 | 1.82 | Upgrade
|
| Property, Plant & Equipment | 1.67 | 0.86 | 0.93 | 1.03 | 0.68 | Upgrade
|
| Long-Term Investments | 0.1 | 0.09 | 0.09 | 0.07 | 0.04 | Upgrade
|
| Other Intangible Assets | 4.96 | 4.08 | 3.63 | 3.15 | 2.84 | Upgrade
|
| Long-Term Deferred Tax Assets | 2.53 | 2.32 | 2.22 | 2.07 | 1.81 | Upgrade
|
| Other Long-Term Assets | 0.01 | - | - | - | - | Upgrade
|
| Total Assets | 14.66 | 11.13 | 9.31 | 8 | 7.18 | Upgrade
|
| Accounts Payable | 0.05 | 0.1 | 0.04 | 0.17 | 0.16 | Upgrade
|
| Accrued Expenses | 0.45 | 0.38 | 0.07 | 0.17 | 0.16 | Upgrade
|
| Current Portion of Long-Term Debt | 0.36 | 0.38 | 0.34 | 0.25 | 0.19 | Upgrade
|
| Current Income Taxes Payable | 0.05 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.87 | 0.4 | 0.54 | 0.68 | 0.29 | Upgrade
|
| Total Current Liabilities | 1.78 | 1.25 | 1 | 1.27 | 0.81 | Upgrade
|
| Long-Term Debt | 0.88 | 1.39 | 1.73 | 0.74 | 0.74 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.03 | 0.59 | 0.66 | 0.69 | 0.59 | Upgrade
|
| Other Long-Term Liabilities | 0.66 | 0.6 | 0.63 | 0.55 | 0.8 | Upgrade
|
| Total Liabilities | 4.35 | 3.84 | 4.02 | 3.25 | 2.93 | Upgrade
|
| Common Stock | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 4.63 | 4.63 | 3.4 | 3.4 | 3.4 | Upgrade
|
| Retained Earnings | 3.43 | 1.32 | 1.45 | 1.21 | 0.7 | Upgrade
|
| Treasury Stock | -0.52 | -0.28 | -0.9 | -0.59 | -0.23 | Upgrade
|
| Comprehensive Income & Other | 2.69 | 1.55 | 1.26 | 0.66 | 0.31 | Upgrade
|
| Shareholders' Equity | 10.31 | 7.29 | 5.29 | 4.75 | 4.25 | Upgrade
|
| Total Liabilities & Equity | 14.66 | 11.13 | 9.31 | 8 | 7.18 | Upgrade
|
| Total Debt | 1.24 | 1.77 | 2.08 | 0.98 | 0.93 | Upgrade
|
| Net Cash (Debt) | 2.2 | 0.76 | -0.97 | -0.26 | 0.35 | Upgrade
|
| Net Cash Growth | 190.78% | - | - | - | 57.68% | Upgrade
|
| Net Cash Per Share | 0.29 | 0.10 | -0.14 | - | 0.05 | Upgrade
|
| Filing Date Shares Outstanding | 7.52 | 7.52 | 6.74 | - | 6.93 | Upgrade
|
| Total Common Shares Outstanding | 7.52 | 7.52 | 6.74 | - | 6.93 | Upgrade
|
| Working Capital | 3.61 | 2.54 | 1.46 | 0.41 | 1.01 | Upgrade
|
| Book Value Per Share | 1.37 | 0.97 | 0.79 | - | 0.61 | Upgrade
|
| Tangible Book Value | 5.35 | 3.22 | 1.66 | 1.6 | 1.42 | Upgrade
|
| Tangible Book Value Per Share | 0.71 | 0.43 | 0.25 | - | 0.20 | Upgrade
|
| Buildings | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Machinery | 2.28 | 1.37 | 1.28 | 1.34 | 0.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.